Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
XPeng
XPEV
$11.4B
| $72.7M | 0.1% |
7,318,700
+1,001,761
| +16% | +$9.03M |
|
227
Lamb Weston
LW
$7.23B
| $72.7M | 0.1% |
814,000
+267,400
| +49% | +$22.7M |
|
228
Aflac
AFL
$60.7B
| $72.7M | 0.1% |
1,010,300
+555,400
| +122% | +$37.2M |
|
229
Equinor
EQNR
$97.2B
| $72.4M | 0.1% |
2,022,723
-394,200
| -16% | -$14.1M |
|
230
Wayfair
W
$14.1B
| $71.8M | 0.1% |
2,183,700
-338,800
| -13% | -$11.8M |
|
231
Academy Sports + Outdoors
ASO
$3.07B
| $71.2M | 0.1% |
1,355,200
-578,100
| -30% | -$27.6M |
|
|
VIVO
232
DELISTED
Meridian Bioscience Inc
VIVO
| $69.8M | 0.1% |
2,100,304
+134,817
| +7% | +$4.34M |
|
233
Cisco
CSCO
$475B
| $69.7M | 0.1% |
1,463,505
-3,446,500
| -70% | -$157M |
|
234
AMN Healthcare
AMN
$1.28B
| $69.7M | 0.1% |
678,000
-25,200
| -4% | -$2.9M |
|
235
Consolidated Edison
ED
$39.8B
| $69.5M | 0.1% |
729,564
-79,200
| -10% | -$7.21M |
|
236
West Pharmaceutical
WST
$24.7B
| $69.4M | 0.09% |
294,700
+95,011
| +48% | +$22.5M |
|
237
United Parks & Resorts
PRKS
$2B
| $69.2M | 0.09% |
1,293,500
+441,000
| +52% | +$23.6M |
|
238
Verizon
VZ
$196B
| $69.1M | 0.09% |
1,754,143
-2,667,550
| -60% | -$101M |
|
239
Futu Holdings
FUTU
$14.7B
| $69M | 0.09% |
1,697,800
+1,507,400
| +792% | +$73.6M |
|
240
Pentair
PNR
$10.7B
| $69M | 0.09% |
1,533,664
+420,000
| +38% | +$18.3M |
|
|
ATVI
241
DELISTED
Activision Blizzard
ATVI
| $68.9M | 0.09% |
900,296
-183,602
| -17% | -$13.6M |
|
242
Arista Networks
ANET
$250B
| $68.5M | 0.09% |
2,258,800
-239,600
| -10% | -$7.37M |
|
243
HSBC
HSBC
$355B
| $68.3M | 0.09% |
2,191,565
-182,378
| -8% | -$5.18M |
|
244
The Mosaic Company
MOS
$7.34B
| $67.9M | 0.09% |
1,547,200
+1,169,215
| +309% | +$57.9M |
|
|
WWE
245
DELISTED
World Wrestling Entertainment
WWE
| $67.5M | 0.09% |
984,500
-127,500
| -11% | -$9.63M |
|
246
UiPath
PATH
$8.14B
| $67.4M | 0.09% |
5,304,887
+1,365,087
| +35% | +$16.9M |
|
247
Enbridge
ENB
$113B
| $67.4M | 0.09% |
1,722,853
+1,305,653
| +313% | +$51.1M |
|
248
RingCentral
RNG
$5.3B
| $66.8M | 0.09% |
1,886,000
-131,500
| -7% | -$4.7M |
|
249
Ford
F
$55.7B
| $66.5M | 0.09% |
+5,721,509
| New | +$73.5M |
|
250
Royal Bank of Canada
RY
$292B
| $66.5M | 0.09% |
706,894
+691,584
| +4,517% | +$65.3M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.